Keith Wayne Ward, Chief Development Officer at REATA PHARMACEUTICALS INC (RETA), sold 9,500 shares at $66.64 ($636K) on 2018-11-07, disclosed to the SEC on 2018-11-08.
Open-market sale of $636k RETA by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.64 | 3,697 | $246K | 38.7% |
| 2 | $66.64 | 3,697 | $246K | 38.7% |
| 3 | $68.13 | 1,053 | $72K | 11.3% |
| 4 | $68.13 | 1,053 | $72K | 11.3% |
| Total | $66.97 avg | 9,500 | $636K | 100% |
| Filing → |
| RETA | SELL | 2019-01-03 | $448K | — | Filing → |
| RETA | SELL | 2018-11-01 | $283K | — | Filing → |
| RETA | SELL | 2018-10-24 | $813K | — | Filing → |